Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2013 - 2026)

Angiodynamics (ANGO) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $5.3 million in Q2 2026.

• Quarterly Non-Current Deferred Tax Liability rose 30.52% year-over-year to $5.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.3 million (up 30.52% YoY) and the FY2026 annual result came in at $5.3 million, up 30.52% from the prior year.
• Non-Current Deferred Tax Liability advanced to $5.3 million in Q2 2026, from $4.6 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $17.8 million in Q4 2023 to a low of $1.3 million in Q3 2023.
• A 5-year average of $8.6 million and a median of $5.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability sank 91.54% — and 2024, when it surged 261.69%.
• Tracing ANGO's Non-Current Deferred Tax Liability over 5 years: stood at $14.3 million in 2022, then climbed by 24.27% to $17.8 million in 2023, then slumped by 75.59% to $4.3 million in 2024, then retreated by 0.07% to $4.3 million in 2025, then rose by 22.74% to $5.3 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $5.3 million (Q2 2026), $4.6 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.